LMRI Lumexa Imaging Holdings, Inc. - Common Stock
$7.11
Price · May 20, 2026
Fundamentals as of May 12, 2026
52W Range
$6–$19
5% of range
Analyst Rating
BUY
14 analysts
Price Target
$19
+165% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
LMRI Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$7.11
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$6 – $19
LMRI Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
LMRI
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
LMRI
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
LMRI
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
LMRI
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
LMRI
Peer Median
LMRI Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
14 analysts
- Strong Buy 6 42.9%
- Buy 7 50.0%
- Hold 1 7.1%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
7 analysts · 2026-05-19
Median
$19.00
← Below all targets
$7.11
Low
$13.00
High
$23.00
Median target
$19.00
+167.2%
Mean target
$18.86
+165.2%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.11%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $0.18 | $0.12 | 0.06% |
| Dec. 31, 2025 | $-0.20 | $0.07 | -0.27% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| LMRI | — | — | — | — | — | — |
| OMDA | $922M | -45.1 | 53.2% | -4.9% | -5.8% | 65.7% |
| INNV | $500M | -16.8 | 11.8% | -3.5% | -12.0% | 18.0% |
| OPK | — | -4.2 | -14.9% | -37.2% | -17.6% | 33.9% |
| TALK | — | — | — | — | — | — |
| CSTL | $1.15B | -46.9 | 3.7% | -7.0% | -5.2% | — |
| FLGT | $816M | -84.7 | 13.8% | -18.8% | -5.4% | 40.6% |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Balance Sheet 20
| Metric | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $59M | |
| Prepaid Expense | $18M | |
| Current Assets | $227M | |
| PP&E (Net) | $145M | |
| Goodwill | $808M | |
| Intangibles | $41M | |
| Other Non-current Assets | $44M | |
| Total Assets | $1.76B | |
| Accounts Payable | $45M | |
| Current Liabilities | $179M | |
| Capital Leases | $71M | |
| Deferred Tax | $41M | |
| Other Non-current Liabilities | $35M | |
| Total Liabilities | $1.18B | |
| Long-term Debt | $834M | |
| Common Stock | $96.0K | |
| Retained Earnings | $-631M | |
| Stockholders' Equity | $586M | |
| Liabilities + Equity | $1.76B | |
| Shares Outstanding | 96,109,927 |
Income Statement 13
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Revenue | $253M | $245M | |
| SG&A Expense | $20M | $17M | |
| Operating Expenses | $248M | $235M | |
| Operating Income | $19M | $26M | |
| Interest Expense | $16M | $30M | |
| Pretax Income | $3M | $-4M | |
| Income Tax | $1M | $3M | |
| Net Income | $2M | $-8M | |
| EPS (Basic) | $0.02 | $-0.11 | |
| EPS (Diluted) | $0.02 | $-0.11 | |
| Shares (Basic) | 95,983,233 | 69,523,369 | |
| Shares (Diluted) | 95,983,243 | 69,523,369 | |
| EBITDA | $19M | · |
Balance Sheet 21
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Cash & Equivalents | $51M | · | |
| Prepaid Expense | $17M | · | |
| Current Assets | $222M | · | |
| PP&E (Net) | $150M | · | |
| Goodwill | $808M | · | |
| Intangibles | $40M | · | |
| Other Non-current Assets | $47M | · | |
| Total Assets | $1.76B | · | |
| Accounts Payable | $37M | · | |
| Current Liabilities | $158M | · | |
| Capital Leases | $71M | · | |
| Deferred Tax | $41M | · | |
| Other Non-current Liabilities | $37M | · | |
| Total Liabilities | $1.16B | · | |
| Long-term Debt | $832M | · | |
| Total Debt | $830M | · | |
| Common Stock | $96.0K | · | |
| Retained Earnings | $-629M | · | |
| Stockholders' Equity | $600M | · | |
| Liabilities + Equity | $1.76B | · | |
| Shares Outstanding | 96,080,735 | · |
Cash Flow 13
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| D&A | $10M | $9M | |
| Stock-based Comp | $12M | $6M | |
| Deferred Tax | $726.0K | $1M | |
| Operating Cash Flow | $3M | $-14M | |
| CapEx | $5M | $1M | |
| Investing Cash Flow | $-5M | $-720.0K | |
| Debt Issued | $1M | $496.0K | |
| Net Debt Issued | $-2M | · | |
| Financing Cash Flow | $-5M | $-4M | |
| Net Change in Cash | $-8M | $-19M | |
| Taxes Paid | $30.0K | $0 | |
| Free Cash Flow | $-2M | · | |
| Levered FCF | $-11M | · |
Profitability 7
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Operating Margin | 7.7% | · | |
| Net Margin | 0.68% | · | |
| Pretax Margin | 1.2% | · | |
| EBITDA Margin | 7.7% | · | |
| ROA | 0.19% | · | |
| ROE | 0.57% | · | |
| ROIC | 0.76% | · |
Liquidity & Solvency 5
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Current Ratio | 1.4 | · | |
| Quick Ratio | 0.3 | · | |
| Debt / Equity | 1.4 | · | |
| LT Debt / Equity | 1.4 | · | |
| Interest Coverage | 1.2 | · |
Efficiency 1
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Asset Turnover | 0.3 | · |
Valuation (TTM) 7
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Market Cap | $826M | · | |
| Enterprise Value | $1.61B | · | |
| P/B | 1.4 | · | |
| P / Cash Flow | 281.8 | · | |
| P / FCF | -346.9 | · | |
| EV / EBITDA | 82.7 | · | |
| EV / FCF | -674.0 | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.